Original Research
Published on 11 Jun 2024
Downregulation of Ripk1 and Nsf mediated by CRISPR-CasRx ameliorates stroke volume and neurological deficits after ischemia stroke in mice
in Neuroinflammation and Neuropathy
![Downregulation of Ripk1 and Nsf mediated by CRISPR-CasRx ameliorates stroke volume and neurological deficits after ischemia stroke in mice](https://www.frontiersin.org/files/myhome article library/1401038/1401038_Thumb_400.jpg)
- 2,542 views
Original Research
Published on 11 Jun 2024
in Neuroinflammation and Neuropathy
Original Research
Published on 03 Jun 2024
in Neuroinflammation and Neuropathy
Original Research
Published on 30 May 2024
in Neuroinflammation and Neuropathy
Original Research
Published on 30 May 2024
in Neuroinflammation and Neuropathy
Original Research
Published on 21 May 2024
in Neuroinflammation and Neuropathy
Mini Review
Published on 07 May 2024
in Neuroinflammation and Neuropathy
Original Research
Published on 26 Apr 2024
in Neuroinflammation and Neuropathy
Review
Published on 12 Apr 2024
in Neuroinflammation and Neuropathy
Review
Published on 03 Apr 2024
in Neuroinflammation and Neuropathy
Editorial
Published on 26 Mar 2024
in Neuroinflammation and Neuropathy
Systematic Review
Published on 26 Mar 2024
in Neuroinflammation and Neuropathy
Original Research
Published on 22 Mar 2024
in Neuroinflammation and Neuropathy
Original Research
Published on 14 Mar 2024
in Neuroinflammation and Neuropathy
Mini Review
Published on 16 Feb 2024
in Neuroinflammation and Neuropathy
Original Research
Published on 15 Feb 2024
in Neuroinflammation and Neuropathy
Editorial
Published on 12 Feb 2024
in Neuroinflammation and Neuropathy